T-2 toxin induces cardiotoxicity by activating ferroptosis and inhibiting heme oxygenase-1

Chi Wang1, Jun He2, Hong Jin2

  • 1Chinese PLA Center for Disease Control and Prevention, Beijing, 100071, China; School of Public Health, China Medical University, Shenyang, 110122, China.

Chemosphere
|September 7, 2023
PubMed

Insights

T-2 toxin induces heart damage by activating ferroptosis, a cell death pathway. Targeting ferroptosis and heme oxygenase-1 (HO-1) may protect against T-2 toxin cardiotoxicity.

Area of Science:

  • Toxicology
  • Cardiovascular Biology
  • Cell Death Mechanisms

Background:

  • T-2 toxin, a Fusarium-derived metabolite, causes cardiotoxicity via unknown mechanisms.
  • Ferroptosis, an iron-dependent cell death, is implicated in cardiovascular damage.

Purpose of the Study:

  • To investigate the role of ferroptosis in T-2 toxin-induced cardiotoxicity.
  • To explore the involvement of heme oxygenase-1 (HO-1) in this process.

Main Methods:

  • Acute cardiotoxicity induced in male mice and human cardiomyocytes using T-2 toxin.
  • Assessed oxidative stress markers, ferroptosis indicators, and HO-1 expression.
  • Utilized ferroptosis inhibitor (Liproxstatin-1) and HO-1 inhibitor (Sn-protoporphyrin).

Main Results:

  • T-2 toxin increased reactive oxygen species, malondialdehyde, and iron (Fe2+).
  • T-2 toxin decreased glutathione, ATP, and glutathione peroxidase 4 levels, activating ferroptosis.
  • Inhibiting ferroptosis with Liproxstatin-1 ameliorated cardiac injury.
  • T-2 toxin downregulated HO-1, exacerbating ferroptosis and oxidative damage.

Conclusions:

  • Ferroptosis is a key mechanism in T-2 toxin-induced cardiotoxicity.
  • Targeting ferroptosis and modulating HO-1 activity offers potential cardioprotective strategies against T-2 toxin exposure.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.6K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.4K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
16.9K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
9
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
617